TUDORZA PRESSAIR: payments to doctors
Payments that named TUDORZA PRESSAIR as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $132K
- Providers
- 4,638
- Transactions
- 7,745
- Average per transaction
- $17
The per-transaction average — $17 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 4,638 providers the average total is $28, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Circassia Pharmaceuticals Inc | $92,413 | 70.1% |
| Covis Pharma GmbH | $27,702 | 21.0% |
| AstraZeneca | $11,737 | 8.9% |